Clinical Trial Update: Primary Percutaneous Pericardiotomy for Malignant Pericardial Effusion (PMAP) [NA]

View source ↗

Summary

The PMAP trial evaluating primary percutaneous pericardiotomy for malignant pericardial effusion has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pericardial Effusion
• Pericardial Effusion

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Pericardial Effusion Malignant | NA | Status: TERMINATED